| 660028 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity |
2021-03-01 |
10.1136/jitc-2020-001793 |
Boreel Daan F, Span Paul N, Bussink Johan |
| 660027 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Host response to immune checkpoint inhibitors contributes to tumor aggressiveness |
2021-03-01 |
10.1136/jitc-2020-001996 |
Khononov Irina, Jacob Eyal, Fremder Ella, Dahan Nili, Harel Michal, Raviv Ziv, Krastev Boris, Shaked Yuval |
| 660026 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis |
2021-03-01 |
10.1136/jitc-2020-002096 |
Gebremeskel Simon, Nelson Adam, Walker Brynn, Oliphant Tora, Lobert Lynnea, Mahoney Douglas, Johnston Brent |
| 660025 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells |
2021-03-01 |
10.1136/jitc-2020-001197 |
Ly Stanley, Anand Vivek, El-Dana Fouad, Nguyen Khoa, Cai Yiming, Cai Shirong, Piwnica-Worms Helen, Tripathy Debasish, Sahin Aysegul A, Andreeff Michael, Battula Venkata Lokesh |
| 660024 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling |
2021-03-01 |
10.1136/jitc-2020-001877 |
Bandey Irfan N, Adolacion Jay R T, Romain Gabrielle, Paniagua Melisa Martinez, An Xingyue, Saeedi Arash, Liadi Ivan, You Zheng, Rajanayake Rasindu B, Hwu Patrick, Singh Harjeet, Cooper Laurence JN, Varadarajan Navin |
| 660023 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer |
2021-03-01 |
10.1136/jitc-2021-002585 |
Gadwa Jacob, Bickett Thomas E, Darragh Laurel B, Knitz Michael William, Bhatia Shilpa, Piper Miles, Van Court Benjamin, Bhuvane Shiv, Nguyen Diemmy, Nangia Varuna, Kleczko Emily K, Nemenoff Raphael A, Karam Sana D |
| 660022 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC) |
2021-03-01 |
10.1136/jitc-2020-001504 |
Ricciuti Biagio, Jones Greg, Severgnini Mariano, Alessi Joao V, Recondo Gonzalo, Lawrence Marissa, Forshew Tim, Lydon Christine, Nishino Mizuki, Cheng Michael, Awad Mark |
| 660021 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer |
2021-03-01 |
10.1136/jitc-2020-001965 |
Bareche Yacine, Pommey Sandra, Carneiro Mayra, Buisseret Laurence, Cousineau Isabelle, Thebault Pamela, Chrobak Pavel, Communal Laudine, Allard David, Robson Simon C, Mes-Masson Anne-Marie, Provencher Diane, Lapointe Rejean, Stagg John |
| 660020 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy |
2021-03-01 |
10.1136/jitc-2020-002035 |
Davari Kathrin, Holland Tristan, Prassmayer Laura, Longinotti Giulia, Ganley Kenneth P, Pechilis Lisa J, Diaconu Iulia, Nambiar Prashant R, Magee Michael S, Schendel Dolores J, Sommermeyer Daniel, Ellinger Christian |
| 660019 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report |
2021-03-01 |
10.1136/jitc-2021-002337 |
Gauci Marie-Léa, Baroudjian Barouyr, Lebbe Celeste, Roux Olivier |
